Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHA in Alzheimer's Disease
NCT00440050Phase 3Completed
- Sponsor
- Alzheimer's Disease Cooperative Study
- Start
- Feb 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docosahexaenoic acid in Alzheimer's disease (AD), sponsored by Alzheimer's Disease Cooperative Study. Started Feb 2007; status: completed.
02
Drugs
docosahexaenoic acid
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00440050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440050.